Product Description
Everolimus Tablets used as animmunosuppressantto preventrejectionoforgan transplantsand in the treatment of renal cell cancer and othertumours. Tags: Everolimus Tablets manufacturer, Everolimus Tablets exporter, Everolimus Tablets supplier, and EverolimusTablets, whogmp approved Everolimus Tablets manufacturer and supplier, EverolimusTablets distributor, Everolimus Tablets drop shipper, EverolimusTablets 5 mgEverolimus Tablets 5 mgsupplier, Everolimus Tablets 5mg.
ISO/GMP/cGMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approvedmanufacturingfacility in Gujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health ofclients country and we also provide the products samples, COA, COPP, ACTD or CTDossier, DMF, Manufacturing license, Free sales certificate and other requireddocuments.
Export Country:Saintroy Lifescience Everolimus Tablets export to USA, Canada, Germany, Europe,France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon,Lebanon, Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand,Singapore, Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso,Niger,Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman,Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia,Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt,Kyrgyzstan, Uzbekistan, Kazakhstan.
Comprehensive Cancer and Transplant SupportEvermil tablets provide effective, targeted therapy for advanced renal cell carcinoma, breast cancer, and neuroendocrine tumors. They are also used to prevent organ rejection in transplant patients. As an mTOR inhibitor, Everolimus disrupts cancer cell growth while supporting immunosuppression, offering a vital option for patients facing multiple conditions under medical guidance.
Convenient and Safe PackagingEach Evermil tablet is packaged in a strip of 10, utilizing blister pack technology to maintain tablet integrity, freshness, and convenient dispensing. Clear batch and expiry details are provided on each pack, ensuring users receive safely stored medication within its two-year shelf life.
Usage and Storage InstructionsFor optimal effectiveness, Evermil tablets should be taken precisely as prescribed, orally with water, and at the same time daily. Always store the medication in a cool, dry place away from direct sunlight and children. Do not use the tablets beyond the expiry date mentioned on the pack.
FAQ's of Everolimus Tablet:
Q: How should Evermil (Everolimus) tablets be administered?
A: Evermil tablets are taken orally, once daily, at the same time each day, as directed by your healthcare provider. Swallow the tablet whole without crushing or chewing, and follow your doctor's instructions closely for best results.
Q: What medical conditions is Evermil prescribed for?
A: Evermil is indicated for the treatment of advanced renal cell carcinoma, breast cancer, neuroendocrine tumors, and in immunosuppression therapy after organ transplantation, as determined by a qualified healthcare professional.
Q: When is the best time to take Evermil tablets?
A: It is recommended to take Evermil tablets at the same time every day to maintain consistent levels in your bloodstream. Follow your doctor's advice regarding the exact timing and daily routine.
Q: Where should Evermil tablets be stored for optimal preservation?
A: Store Evermil in its original blister packaging at a cool, dry place away from direct sunlight and moisture. Keep the medication out of the reach of children and do not use after the expiry date stated on the pack.
Q: What is the process for obtaining Evermil tablets?
A: Evermil is a prescription-only medicine available through authorized medical channels such as pharmacists, dealers, and distributors in India. Consult your doctor for a prescription and obtain it from licensed suppliers.
Q: What are the main benefits of using Evermil tablets?
A: Evermil's primary benefits include slowing the progression of certain cancers and preventing organ rejection post-transplant by inhibiting cell proliferation. Its efficacy makes it an essential component in cancer and transplant treatment plans.